77 related articles for article (PubMed ID: 7847397)
1. 111 cases of hepatitis C linked to Gammagard. Patient screening recommended.
Am J Hosp Pharm; 1994 Oct; 51(19):2326. PubMed ID: 7847397
[No Abstract] [Full Text] [Related]
2. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(28):505-9. PubMed ID: 8022396
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis C following administration of intravenous immunoglobulins].
Cabrera Chaves T; Simón Marco MA; Gomollón García F; Botella Esteban MT; Uribarrena Echebarría R
Gastroenterol Hepatol; 1996; 19(6):305-8. PubMed ID: 8754418
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
Berger A; Doerr HW; Scharrer I; Weber B
J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728
[TBL] [Abstract][Full Text] [Related]
5. HCV and Gammagard in France.
Gomperts ED
Lancet; 1994 Jul; 344(8916):201. PubMed ID: 7912801
[No Abstract] [Full Text] [Related]
6. Follow-up studies of hepatitis C association with an intravenous immunoglobulin.
Yu MW
Dev Biol Stand; 1996; 88():215-6. PubMed ID: 9119139
[No Abstract] [Full Text] [Related]
7. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker.
Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P
Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C and immune globulin.
López-Jiménez J; Odriozola J; Pérez-Oteyza J; García-Laraña J
N Engl J Med; 1995 May; 332(18):1235-6. PubMed ID: 7700324
[No Abstract] [Full Text] [Related]
9. Hepatitis C and immune globulin.
Prince AM; Horowitz B
N Engl J Med; 1995 May; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
[No Abstract] [Full Text] [Related]
10. Hepatitis C and immune globulin.
Douglas SD; Slade HB
N Engl J Med; 1995 May; 332(18):1235; author reply 1236-7. PubMed ID: 7700323
[No Abstract] [Full Text] [Related]
11. The safety of immune globulins.
Tepper M; Gully P
Can Commun Dis Rep; 1996 Jul; 22(14):117-9. PubMed ID: 8754937
[No Abstract] [Full Text] [Related]
12. Transmission of viral infections through intravenous immune globulin.
Schiff RI
N Engl J Med; 1994 Dec; 331(24):1649-50. PubMed ID: 7969346
[No Abstract] [Full Text] [Related]
13. Experimental experience with virus validation studies.
Willkommen H
Dev Biol Stand; 1996; 88():317-8. PubMed ID: 9119155
[No Abstract] [Full Text] [Related]
14. Gammagard and reported hepatitis C virus episodes.
Gomperts ED
Clin Ther; 1996; 18 Suppl B():3-8. PubMed ID: 8930438
[TBL] [Abstract][Full Text] [Related]
15. Transmission of hepatitis after the administration of intravenous immunoglobulins.
Rousell RH; Dobkin MB; Budinger MD; Louie RE
Am J Clin Pathol; 1993 May; 99(5):649. PubMed ID: 8493958
[No Abstract] [Full Text] [Related]
16. Hepatitis C from immunoglobin infusions.
Lehner PS; Webster AD
BMJ; 1993 Jun; 306(6891):1541-2. PubMed ID: 8518699
[No Abstract] [Full Text] [Related]
17. Unusual course of the hepatitis C virus infection in one patient diagnosed of common variable immunodeficiency.
Múñoz FJ; de la Calle A; Giménez MJ; González J; Conde J
Allergol Immunopathol (Madr); 1995; 23(6):263-6. PubMed ID: 8579003
[TBL] [Abstract][Full Text] [Related]
18. Side-effects of intravenous immune globulins.
Duhem C; Dicato MA; Ries F
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
[TBL] [Abstract][Full Text] [Related]
19. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.
Razvi S; Schneider L; Jonas MM; Cunningham-Rundles C
Clin Immunol; 2001 Dec; 101(3):284-8. PubMed ID: 11726220
[TBL] [Abstract][Full Text] [Related]
20. Viral transmission by blood products: a perspective of events covered by the recent tribunal of enquiry into the Irish Blood Transfusion Board.
Yap PL
Ir Med J; 1997; 90(3):84, 86, 88. PubMed ID: 9183082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
